Warning letter
Pascal Company, Inc.: warning letter of Aug 9, 2006
FDA warning letter UCM076024 · Seattle District Office
Key facts
| Reference number | UCM076024 |
|---|---|
| Company | Pascal Company, Inc. |
| Subject | CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Aug 9, 2006 |
| Posted date | Aug 9, 2006 |
| Issuing office | Seattle District Office |
| Product type | Drugs |
| CFR sections cited | 211.198, 211.22(c), 211.67(b), 211.100(a), 211.113(a), 211.166(a), 211.63, 211.192 |
| Country | 3 |
| Inspection city | Bellevue |
| Inspection ZIP | 98004-1430 |
| Inspection start date | Mar 28, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: